Abstract:Angiogenesis is the formation of new blood vessels from the existing vasculature, which is involved in multiple biological processes, including atherosclerosis, ischemic heart disease, and cancer. Ginsenoside-Rb1 (Rb1), the most abundant ginsenoside isolated form Panax ginseng, has been identified as a promising anti-angiogenic agent via the up-regulation of PEDF. However, the underlying molecular mechanisms still unknown. In the present study, human umbilical vein endothelial cells (HUVECs) were selected to perform in vitro assays. Rb1 (0–20 nM) treatment induced pigment epithelial-derived factor (PEDF) protein expression in concentration and time-dependent manners. Interestingly, it was also demonstrated that the exposure of Rb1 (10 nM) could increase PEDF protein expression without any alteration on mRNA level, suggesting the involvement of posttranscriptional regulation. Furthermore, bioinformatics predictions indicated the regulation of miR-33a on PEDF mRNA 3′-UTR, which was further confirmed by luciferase reporter gene assay and real-time PCR. Over-expression of pre-miR-33a was found to regress partly Rb1-mediated PEDF increment and anti-angiogenic effect in HUVECs. Additionally, Rb1-reduced miR-33a and increased PEDF expression was prevented by pre-incubation with peroxisome proliferator-activated receptor-γ (PPAR-γ) antagonist (GW9662) or transfection with PPAR-γ siRNA in HUVECs. Taken together, our findings demonstrated that Rb1 exerted anti-angiogenic effects through PPAR-γ signaling pathway via modulating miR-33a and PEDF expressions. Thus, Rb1 may have the potential of being developed as an anti-angiogenic agent, however, further appropriate studies are warranted to evaluate the effect in vivo.

Ginsenoside Rd Regulates the Akt/mTOR/p70S6K Signaling Cascade and Suppresses Angiogenesis and Breast Tumor Growth.

Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expression

Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line.

Ginsenoside Rd from Panax Notoginseng is Cytotoxic Towards HeLa Cancer Cells and Induces Apoptosis

Ginsenoside Rk1 Induces Cell Cycle Arrest and Apoptosis in MDA-MB-231 Triple Negative Breast Cancer Cells.

Ginsenoside Rg5 Induces Apoptosis and Autophagy Via the Inhibition of the PI3K/Akt Pathway Against Breast Cancer in a Mouse Model

Ginsenoside-Rb1-Mediated Anti-angiogenesis Via Regulating PEDF and Mir-33A Through the Activation of PPAR-γ Pathway

[Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma].

The Angiosuppressive Effects of 20(R)- Ginsenoside Rg3

Effects and Mechanism of Rhodiola in Inhibiting Angiogenesis in Human Breast Cancer

The Preparation of Ginsenoside Rg5, Its Antitumor Activity Against Breast Cancer Cells and Its Targeting of PI3K.

The Anti-Tumor Effect of Ginsenoside Rh4 in MCF-7 Breast Cancer Cells in Vitro and in Vivo.

Antitumor Activity of Ginsenoside Rd in Gastric Cancer Via Up-Regulation of Caspase-3 and Caspase-9.

Ginsenoside Rh2 inhibits breast cancer cell growth via<?A3B2 ACK?>ERβ-TNFα pathway

[Effect of Ginsenoside Rg3 on the Progression of Orthotopically Xenotransplanted Human Breast Cancer in Nude Mice and Its Mechanism].

Ginsenoside Rg3 Targets Cancer Stem Cells and Tumor Angiogenesis to Inhibit Colorectal Cancer Progression in Vivo

Ginsenoside Rd Inhibits Glioblastoma Cell Proliferation by Up-Regulating the Expression of Mir-144-5p

Natural Product Ginsenoside 25-Och3-ppd Inhibits Breast Cancer Growth and Metastasis Through Down-Regulating Mdm2

Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells

Raddeanin A, a Triterpenoid Saponin Isolated from Anemone Raddeana, Suppresses the Angiogenesis and Growth of Human Colorectal Tumor by Inhibiting VEGFR2 Signaling.

Anti-angiogenic Effect of Ginsenoside Rg3 in Nude Mice Cervical Cancer